Related Experiment Video
Updated: Jul 20, 2026
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Obesity and kidney transplantation
Titte R Srinivas1, Herwig-Ulf Meier-Kriesche
1University of Florida, Gainesville, Fla., USA.
Contributions to Nephrology
|August 25, 2006
Summary
Obesity presents challenges before and after kidney transplantation, leading to serious health issues. This review covers obesity
Area of Science:
- Nephrology
- Transplantation Medicine
- Metabolic Diseases
Background:
- Obesity is a growing concern in kidney transplant recipients.
- Obesity complicates kidney transplantation and worsens patient outcomes.
Purpose of the Study:
- To review the epidemiology and pathophysiology of obesity in kidney transplant recipients.
- To provide an overview of clinical studies on obesity in renal transplantation.
- To present an evidence-based approach to managing obesity in this population.
Main Methods:
- Literature review of clinical studies.
- Analysis of epidemiological data.
- Discussion of pathophysiological mechanisms.
Main Results:
- Obesity is linked to adverse metabolic and cardiovascular consequences in transplant recipients.
- These consequences significantly contribute to morbidity and mortality post-transplantation.
Conclusions:
- Managing obesity is crucial for improving outcomes in kidney transplant recipients.
- A comprehensive approach is needed to address obesity in this patient group.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...